Characterization of 34 novel and six known MTM1 gene mutations in 47 unrelated X-linked myotubular myopathy patients

Area of Science:

• Genetics
• Molecular Biology
• Neuromuscular Disorders

Background:

• X-linked myotubular myopathy (XLMTM) is a severe congenital muscle disorder primarily affecting newborn males, often leading to rapid mortality.
• The gene responsible for XLMTM, MTM1, was identified in 1996, with previous studies documenting mutations in 90 patients.

Purpose of the Study:

• To identify novel mutations in the MTM1 gene in a cohort of 53 patients with XLMTM.
• To characterize the spectrum of MTM1 mutations and investigate their origins and distribution across different ethnic backgrounds.

Main Methods:

• Genomic DNA and mRNA screening protocols were employed to analyze MTM1 in 53 patients.
• Mutation analysis included identification of large deletions, nonsense, frameshift, missense, and splice-site mutations, as well as intronic variants causing exon skipping.

Main Results:

• Thirty-four novel MTM1 mutations were identified in 37 patients, alongside six known mutations in 10 other patients.
• The newly identified mutations comprised five large deletions, eight nonsense, six frameshift, five missense, and eight splice-site mutations.
• Two intronic variants leading to partial exon skipping were reported for the first time in MTM1, and deletions in exons 1 and 15 were identified.

Conclusions:

• The study identified a significant number of novel MTM1 mutations, expanding the known mutational spectrum for XLMTM.
• The genetic heterogeneity and unique MTM1 mutations found in most XLMTM families suggest diverse mutational origins and the need for individualized genetic diagnostics.